Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Effect of influenza vaccine on markers of inflammation and lipid profile
Michael Y. Tsai
, Naomi Q. Hanson
,
Robert J. Straka
, Tracy R. Hoke
, Jose M. Ordovas
, James M. Peacock
, Valerie L. Arends
, Donna K. Arnett
Laboratory Medicine and Pathology
Experimental and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
82
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effect of influenza vaccine on markers of inflammation and lipid profile'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Influenza Vaccine
100%
Influenza Vaccination
100%
Inflammation Markers
100%
Lipid Profile
100%
Lipids
75%
Mean Concentration
75%
Vaccination
50%
Monocyte Chemoattractant protein-1 (MCP-1)
50%
Interleukin-2
50%
Interleukin-6
50%
Inflammatory Markers
50%
Serum Amyloid A
50%
C-reactive Protein
50%
Absolute Value
50%
Tumor Necrosis Factor-α
50%
Soluble Receptor
50%
Normalized Value
50%
Epidemiologic
25%
Cardiovascular Disease
25%
Clinical Assessment
25%
Epidemiologic Studies
25%
Healthy Individuals
25%
Triglycerides
25%
Protein Value
25%
High-sensitivity C-reactive Protein (hs-CRP)
25%
Transient Changes
25%
Difference in Means
25%
Plasma Lipid Concentration
25%
Veterinary Science and Veterinary Medicine
Influenza Vaccine
100%
Live Attenuated Influenza Vaccine
100%
Inflammation
100%
Lipid
100%
Influenza
80%
C Reactive Protein
60%
C-Reactive Protein
60%
Blood Plasma
40%
Neoplasm
40%
Serum Amyloid A
40%
Monocyte
40%
Necrosis
40%
Diseases
20%
Neuroscience
Lipid
100%
Influenza Vaccine
100%
Live Attenuated Influenza Vaccine
100%
C-Reactive Protein
60%
Interleukin 6
40%
Monocyte Chemotactic Protein 1
40%
Serum Amyloid A
40%
Necrosis
40%
Blood Plasma
40%
Soluble Interleukin 2 Receptor
40%
Clinical Assessment
20%
Cardiovascular System
20%
Triacylglycerol
20%
Biological Marker
20%